Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IBC 2024 | Early screening in lymphoma: current perspectives & future outlooks

Jessica Okosun and Sandrine Roulland • 25 Mar 2024
IBC 2024
Lymphoma Non-Hodgkin Lymphoma

In this discussion, Jessica Okosun, MA, MB BChir, MRCP, FRCPath, PhD, Barts Cancer Institute, London, UK, and Sandrine Roulland, PharmD, PhD, Centre d’Immunologie Marseille-Luminy (CIML), Marseille, France, share their thoughts on whether there is a role for early detection and screening in patients with lymphoma, and comment on challenges with implementing this in clinical practice. This session was filmed at IBC 2024, held in Lisbon, Portugal.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Jessica Okosun

3:46
The relevance of follicular lymphoma pathogenesis in clinical practice
Jessica Okosun • 6 Sep 2021
2:13
MRD for decision making in follicular lymphoma
Jessica Okosun • 6 Sep 2021
1:47
The influence of the TME on progression and outcomes in follicular lymphoma
Jessica Okosun • 6 Sep 2021
6:23
Molecular classification, biology-based clinical trials and liquid biopsy in lymphoma
Jessica Okosun • 24 Aug 2020

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals